BioProtect Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 130

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $270M

BioProtect General Information

Description

Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer radiation therapy. The company's system acts as a spacer for the protection of healthy tissues in patients receiving radiotherapy for prostate cancer, enabling healthcare institutions to decrease the probability of serious and chronic radiation side effects while improving biochemical tumor control.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 8 Tsor Street
  • Tzur Yigal 4486200
  • Israel
+972
Primary Industry
Therapeutic Devices
Corporate Office
  • 8 Tsor Street
  • Tzur Yigal 4486200
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioProtect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 02-Jun-2026 $270M Completed Generating Revenue
16. Later Stage VC 01-May-2025 Completed Generating Revenue
15. Secondary Transaction - Private Completed Generating Revenue
14. Later Stage VC 27-Sep-2023 Completed Generating Revenue
13. Grant 02-Mar-2023 Completed Generating Revenue
12. Debt - General 19-Aug-2022 Completed Generating Revenue
11. Later Stage VC (Series D) 21-Sep-2020 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
9. Later Stage VC (Series C) 13-Apr-2017 $3.62M $12.8M Completed Generating Revenue
8. Later Stage VC (Series B) 01-Jun-2016 $500K $9.2M Completed Generating Revenue
To view BioProtect’s complete valuation and funding history, request access »

BioProtect Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred C2
Preferred C1
Preferred B
Preferred A4
Preferred A3
Preferred A2
Preferred A1 2,838 $350 $350 1x $350 0.18%
Preferred A 4,500 $141.52 $141.52 1x $141.52 0.26%
To view BioProtect’s complete cap table history, request access »

BioProtect Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer ra
Therapeutic Devices
Tzur Yigal, Israel
130 As of 2026

Marlborough, MA
 

East Providence, RI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioProtect Competitors (2)

One of BioProtect’s 2 competitors is Boston Scientific, a Corporation company based in Marlborough, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boston Scientific Corporation Marlborough, MA
IlluminOss Private Equity-Backed East Providence, RI
You’re viewing 2 of 2 competitors. Get the full list »

BioProtect Patents

BioProtect Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026099743-A1 Positioning a spacer inside a body Pending 08-Nov-2024
US-20260033854-A1 Positioning an inflatable bladder inside a body Pending 02-Aug-2024
WO-2026028088-A1 Positioning an inflatable bladder inside a body Pending 02-Aug-2024
EP-4489700-A2 Apparatus and method for protecting biological tissue during cryotherapy Pending 13-May-2022
EP-4489700-A4 Apparatus and method for protecting biological tissue during cryotherapy Pending 13-May-2022 A61B18/02
To view BioProtect’s complete patent history, request access »

BioProtect Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioProtect Former Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
AJJS Holdings Venture Capital Minority
Accelmed Growth/Expansion Minority
Almeda Ventures Venture Capital Majority
Aran Research Development & Prototypes Corporation Minority
Consensus Business Group Asset Manager Minority
You’re viewing 5 of 23 investors. Get the full list »

BioProtect FAQs

  • When was BioProtect founded?

    BioProtect was founded in 2004.

  • Where is BioProtect headquartered?

    BioProtect is headquartered in Tzur Yigal, Israel.

  • What is the size of BioProtect?

    BioProtect has 130 total employees.

  • What industry is BioProtect in?

    BioProtect’s primary industry is Therapeutic Devices.

  • Is BioProtect a private or public company?

    BioProtect is a Private company.

  • What is the current valuation of BioProtect?

    The current valuation of BioProtect is .

  • What is BioProtect’s current revenue?

    The current revenue for BioProtect is .

  • How much funding has BioProtect raised over time?

    BioProtect has raised $67.9M.

  • Who are BioProtect’s investors?

    AJJS Holdings, Accelmed, Almeda Ventures, Aran Research Development & Prototypes, and Consensus Business Group are 5 of 23 investors who have invested in BioProtect.

  • Who are BioProtect’s competitors?

    Boston Scientific and IlluminOss are competitors of BioProtect.

  • When was BioProtect acquired?

    BioProtect was acquired on 02-Jun-2026.

  • Who acquired BioProtect?

    BioProtect was acquired by Olympus (Diagnostic Equipment).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process